viernes, 26 de enero de 2018

BMC Immunology | Home page

BMC Immunology | Home page

BMC series logo

BMC Immunology

Featured article: Fighting cancer with the immune system

Studies have shown the immune system has the potential to remove tumor cells in a patient’s body. This article describes a method for generating antitumor  cytotoxic T lymphocytes (CTLs)  specific for the epitopes of the HER2/neu tumor-associated antigen. These CTLs are then shown to have a pronounced cytotoxic effect on tumor cells expressing the HER2/neu marker.
Read More


View all articles 

No hay comentarios:

Publicar un comentario